| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/03/2011 | EP2350083A1 Pyrido [5, 4-d]pyrimidines as cell proliferation inhibitors |
| 08/03/2011 | EP2350081A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 08/03/2011 | EP2350080A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 08/03/2011 | EP2350076A2 Imidazoý1,2- ¨pyridinyl bisphosphonates |
| 08/03/2011 | EP2350070A1 Pyridopyrimidinone inhibitors of pi3k and mtor |
| 08/03/2011 | EP2350063A1 Therapeutic macrolide compounds and their use |
| 08/03/2011 | EP2350058A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 08/03/2011 | EP2350057A2 Novel salts of sunitinib |
| 08/03/2011 | EP2350052A2 Antiproliferative compounds |
| 08/03/2011 | EP2350031A2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 08/03/2011 | EP2350030A1 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof |
| 08/03/2011 | EP2350026A1 Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine |
| 08/03/2011 | EP2350012A2 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders |
| 08/03/2011 | EP2350005A1 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b |
| 08/03/2011 | EP2350001A1 Novel benzylidene-indolinone and their medical and diagnostic uses |
| 08/03/2011 | EP2349999A1 Allosteric protein kinase modulators |
| 08/03/2011 | EP2349995A1 Selective seprase inhibitors |
| 08/03/2011 | EP2349991A1 Transition metal complexes of bis[thiohydrazide amide] compounds |
| 08/03/2011 | EP2349990A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 08/03/2011 | EP2349347A2 Hpma - docetaxel or gemcitabine conjugates and uses therefore |
| 08/03/2011 | EP2349346A1 Compositions and methods for achieving sustained therapeutic drug concentrations in a subject |
| 08/03/2011 | EP2349344A1 Compounds |
| 08/03/2011 | EP2349343A2 Polymeric composition with synergistic effect in treatment of tumour diseases |
| 08/03/2011 | EP2349340A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 08/03/2011 | EP2349328A1 Methods for the treatment of cancer |
| 08/03/2011 | EP2349323A2 Methods of using corticotropin-releasing factor for the treatment of cancer |
| 08/03/2011 | EP2349313A1 Combination therapy with peptide epoxyketones |
| 08/03/2011 | EP2349296A1 Engineered synergistic oncolytic viral symbiosis |
| 08/03/2011 | EP2349283A2 Triperpenoid 2-deoxy glycosides and use thereof as medicaments |
| 08/03/2011 | EP2349275A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor |
| 08/03/2011 | EP2349268A1 3, 3', 4, 4'-tetrahydroxy-2, 2'-bipyridine-n, n'-dioxides for the treatment of renal cell carcinoma |
| 08/03/2011 | EP2349259A1 Inhibitors of mitosis for increasing apoptosis in therapy |
| 08/03/2011 | EP2349252A2 Synergistic combination of sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| 08/03/2011 | EP2349239A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 08/03/2011 | EP2349235A1 Use of catecholic butane derivatives in cancer therapy |
| 08/03/2011 | EP2349234A1 New formulations with anti-neoplastic activity |
| 08/03/2011 | EP2348860A1 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 08/03/2011 | EP2348845A1 Ansamycin hydroquinone compositions |
| 08/03/2011 | EP2348843A1 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same |
| 08/03/2011 | EP1963295B1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives |
| 08/03/2011 | EP1893612B1 Pyrrolo [2, 3-b]pyridine derivatives as protein kinase inhibitors |
| 08/03/2011 | EP1860119B1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| 08/03/2011 | EP1802633B1 Benzothieno[2,3-d]pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases |
| 08/03/2011 | EP1786905B1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 08/03/2011 | EP1688432B1 Igm high concentration stabilized solution |
| 08/03/2011 | EP1446104B2 Spray drying methods |
| 08/03/2011 | EP1317282B1 Vectors for molecule delivery to cd11b expressing cells |
| 08/03/2011 | EP1232168B1 Synthetic lipid-a analogs and uses thereof |
| 08/03/2011 | CN1997629B Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 08/03/2011 | CN1901937B Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia |
| 08/03/2011 | CN1898240B Imidazopyrazine tyrosine kinase inhibitors |
| 08/03/2011 | CN1850276B Taxol polymer bond drug lyophilized powder injection and its preparing method |
| 08/03/2011 | CN102143978A Anti- P2X7 peptides and epitopes |
| 08/03/2011 | CN102143977A Multispecific antibodies |
| 08/03/2011 | CN102143958A Pyridazine derivatives as SMO inhibitors |
| 08/03/2011 | CN102143953A Pyrimidines, triazines and their use as pharmaceutical agents |
| 08/03/2011 | CN102143947A Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 08/03/2011 | CN102143942A Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 08/03/2011 | CN102143936A Platinum complex and medical compound containing same |
| 08/03/2011 | CN102143762A Compounds |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102143746A CDK modulators |
| 08/03/2011 | CN102140473A Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/03/2011 | CN102140471A Oligo-nucleic acid for suppressing tumor growth and application thereof |
| 08/03/2011 | CN102140470A Human miR-1236 antisense ribonucleic acid and application thereof |
| 08/03/2011 | CN102140469A Human miR (microRNA)-1233 antisensenucleic acid and application thereof |
| 08/03/2011 | CN102140468A Human miR-185* antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140467A Human miR-365 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140466A Human miR-1825 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140465A Human miR-1249 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140464A Human miR-1238 antisense nucleic acid and applications thereof |
| 08/03/2011 | CN102140463A Human miR (microRNA)-1296 antisensenucleic acid and application thereof |
| 08/03/2011 | CN102140462A Human miR-1260 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140139A Antitumor human single-chain antibody |
| 08/03/2011 | CN102140093A Pyridine amide derivatives, preparation method thereof and application thereof in medicines |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102139117A Application of TOB1 genes in preparation of medicaments for inhibiting breast cancer metastasis |
| 08/03/2011 | CN102139107A Anticancer effect of antagonist of neurokinin receptor |
| 08/03/2011 | CN102139097A Pharmaceutical composition for treating cancers and preparation method thereof |
| 08/03/2011 | CN102139085A Preparation method for traditional Chinese medicine and oral liquid thereof for relieving symptoms and supporting right |
| 08/03/2011 | CN102139037A Application of rhizoma paridis total saponins in preparation of adjuvant drugs of anti-cancer drugs |
| 08/03/2011 | CN102139019A Application of camellia oleifera peel extract |
| 08/03/2011 | CN102138991A Pharmaceutical composition for treating oral cancer and skin cancer |
| 08/03/2011 | CN102138957A Colocynth extract, and production method and application thereof |
| 08/03/2011 | CN102138942A Composite probiotics for prevention and adjuvant therapy of cancers and preparation method thereof |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN102138927A Chloroquine and adriamycin co-supported liposome and preparation method thereof |
| 08/03/2011 | CN102138921A Application of phthalimide derivatives to preparation of anti-angiogenesis medicaments |
| 08/03/2011 | CN102138916A Levo-gossypol for treating tumors or cyclodextrin clathrate compound of acetate thereof |
| 08/03/2011 | CN102138909A Asparaginase freeze-dried powder injection and preparation method thereof, as well as asparaginase solution |
| 08/03/2011 | CN102138903A Everolimus solid oral medicinal composition |
| 08/03/2011 | CN102138898A Nanometer liposome serving as antitumor medicament |
| 08/03/2011 | CN102138896A Clofarabine injection and preparation method thereof |
| 08/03/2011 | CN102138889A Targeted drug-bearing ultrasonic microbubble and preparation method thereof |
| 08/03/2011 | CN101716215B Quality detection method of traditional Chinese medicine of isatis root |
| 08/03/2011 | CN101716134B 2-methoxyestradiol transdermal liniment and 2-methoxyestradiol transdermal patch |
| 08/03/2011 | CN101690820B Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof |
| 08/03/2011 | CN101670056B Medicament for treating malignant tumor |
| 08/03/2011 | CN101653575B Extractive of combined prescription of ophiopogon deccotion and phragmitis decoction and application thereof in preparing medicament for restraining proliferation of lung adenocarcinoma cell A549 |
| 08/03/2011 | CN101633640B Naphthalimide derivative |